Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Cash from Investing Activities (2016 - 2025)

IGC Pharma has reported Cash from Investing Activities over the past 16 years, most recently at -$374000.0 for Q3 2025.

  • Quarterly Cash from Investing Activities fell 475.38% to -$374000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$40000.0 through Sep 2025, up 93.1% year-over-year, with the annual reading at -$442000.0 for FY2025, 39.43% down from the prior year.
  • Cash from Investing Activities was -$374000.0 for Q3 2025 at IGC Pharma, down from $580000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $1.9 million in Q1 2021 and troughed at -$553000.0 in Q1 2022.
  • The 5-year median for Cash from Investing Activities is -$65000.0 (2024), against an average of $20947.4.
  • Year-over-year, Cash from Investing Activities crashed 2520.0% in 2024 and then soared 542.75% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$49000.0 in 2021, then skyrocketed by 65.31% to -$17000.0 in 2022, then plummeted by 258.82% to -$61000.0 in 2023, then crashed by 70.49% to -$104000.0 in 2024, then crashed by 259.62% to -$374000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Cash from Investing Activities are -$374000.0 (Q3 2025), $580000.0 (Q2 2025), and -$142000.0 (Q1 2025).